Demographic characterization of 57 healthy, HIV-uninfected children of either HIV-infected or HIV-uninfected mothers (data from 25 vertically HIV-infected children included in the study are shown as well)
| . | SR children (n = 42) . | UC children (n = 15) . | HIV+ children (n = 25) . |
|---|---|---|---|
| Age (y) | 7.2 ± 2.8 | 6.2 ± 4.0 | 5.8 ± 3.7 |
| Age < 5 y | 6/42 (14%) | 2/15 (13%) | 5/25 (20%) |
| CD4 (cells/μL) | 1278 ± 408 | 1551 ± 534 | 1158 ± 797 |
| Cesarean section | 4/42 | 2/15 | 4/25 |
| ZDV prophylaxis | 0/42 | 0/15 | 0/25 |
| HCV infection | 3/42 | 0/15 | 1/25 |
| CMV infection | 1/42 | 0/15 | 2/25 |
| . | SR children (n = 42) . | UC children (n = 15) . | HIV+ children (n = 25) . |
|---|---|---|---|
| Age (y) | 7.2 ± 2.8 | 6.2 ± 4.0 | 5.8 ± 3.7 |
| Age < 5 y | 6/42 (14%) | 2/15 (13%) | 5/25 (20%) |
| CD4 (cells/μL) | 1278 ± 408 | 1551 ± 534 | 1158 ± 797 |
| Cesarean section | 4/42 | 2/15 | 4/25 |
| ZDV prophylaxis | 0/42 | 0/15 | 0/25 |
| HCV infection | 3/42 | 0/15 | 1/25 |
| CMV infection | 1/42 | 0/15 | 2/25 |
SR = healthy HIV-uninfected children of HIV-infected mothers (seroreverters); UC = healthy children of HIV-negative women (uninfected controls); HIV+ = HIV-infected children; ZDV = zidovudine; HCV = hepatitis C virus; CMV = cytomegalovirus.
Mean values ± standard deviations are shown.